RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Comparison of Parecoxib and Proparacetamol in Endoscopic Nasal Surgery Patients

      한글로보기

      https://www.riss.kr/link?id=A101618219

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The aim of the study was to compare the efficacy of parecoxib for postoperative analgesia after endoscopic turbinate and sinus surgery with the prodrug of acetaminophen, proparacetamol. Materials and Methods: Fifty American Society of Anesthesiology (ASA) physical status I-II patients, receiving functional endoscopic sinus surgery (FESS) and endoscopic turbinectomy, were investigated in a prospective, randomized, double-blind manner. After local infiltration with 1% mepivacaine, patients were randomly allocated to receive intravenous (IV) administration of either 40mg of parecoxib (n=25) or 2g of proparacetamol (n=25) 15 min before discontinuation of total IV anaesthesia with propofol and remifentanil. A blinded observer recorded the incidence and severity of pain at admission to the post anaesthesia care unit (PACU) at 10, 20, and 30 min after PACU admission, and every 1 h thereafter for the first 6 postoperative h. Results: The area under the curve of VAS (AUCVAS) calculated during the study period was 669 (28-1901) cm‧min in the proparacetamol group and 635 (26-1413) cm‧min in the parecoxib group (p=0.34). Rescue morphine analgesia was required by 14 patients (56%) in the proparacetamol group and 12 patients (48%) in the parecoxib (p≥0.05), while mean morphine consumption was 5-3.5mg and 5-2.0mg in the proparacetamol groups and parecoxib, respectively (p≥0.05). No differences in the incidence of side effects were recorded between the 2 groups. Patient satisfaction was similarly high in both groups, and all patients were uneventfully discharged 24h after surgery. Conclusion: In patients undergoing endoscopic nasal surgery, prior infiltration with local anaesthetics, parecoxib administered before discontinuing general anaesthetic, is not superior to proparacetamol in treating early postoperative pain.
      번역하기

      Purpose: The aim of the study was to compare the efficacy of parecoxib for postoperative analgesia after endoscopic turbinate and sinus surgery with the prodrug of acetaminophen, proparacetamol. Materials and Methods: Fifty American Society of Anesthe...

      Purpose: The aim of the study was to compare the efficacy of parecoxib for postoperative analgesia after endoscopic turbinate and sinus surgery with the prodrug of acetaminophen, proparacetamol. Materials and Methods: Fifty American Society of Anesthesiology (ASA) physical status I-II patients, receiving functional endoscopic sinus surgery (FESS) and endoscopic turbinectomy, were investigated in a prospective, randomized, double-blind manner. After local infiltration with 1% mepivacaine, patients were randomly allocated to receive intravenous (IV) administration of either 40mg of parecoxib (n=25) or 2g of proparacetamol (n=25) 15 min before discontinuation of total IV anaesthesia with propofol and remifentanil. A blinded observer recorded the incidence and severity of pain at admission to the post anaesthesia care unit (PACU) at 10, 20, and 30 min after PACU admission, and every 1 h thereafter for the first 6 postoperative h. Results: The area under the curve of VAS (AUCVAS) calculated during the study period was 669 (28-1901) cm‧min in the proparacetamol group and 635 (26-1413) cm‧min in the parecoxib group (p=0.34). Rescue morphine analgesia was required by 14 patients (56%) in the proparacetamol group and 12 patients (48%) in the parecoxib (p≥0.05), while mean morphine consumption was 5-3.5mg and 5-2.0mg in the proparacetamol groups and parecoxib, respectively (p≥0.05). No differences in the incidence of side effects were recorded between the 2 groups. Patient satisfaction was similarly high in both groups, and all patients were uneventfully discharged 24h after surgery. Conclusion: In patients undergoing endoscopic nasal surgery, prior infiltration with local anaesthetics, parecoxib administered before discontinuing general anaesthetic, is not superior to proparacetamol in treating early postoperative pain.

      더보기

      참고문헌 (Reference)

      1 Practice guidelines for acute pain management in the perioperative setting, "an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management" 100 : 1573-1581, 2004

      2 Church CA, "Rofecoxib versus hydrocodone/acetaminophen for postoperative analgesia in functional endoscopic sinus surgery" 116 : 602-606, 2006

      3 Rømsing J, "Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia" 88 : 215-226, 2002

      4 Zhou TJ, "Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement" 92 : 1569-1575, 2001

      5 Dalpiaz AS, "Parecoxib: a shift in pain management?" 4 : 165-177, 2004

      6 Papadima A, "Parecoxib vs. Lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial" 24 : 154-158, 2007

      7 Cheer SM, "Parecoxib (parecoxib sodium)" 61 : 1133-1143, 2001

      8 Slack R, "Functional endoscopic sinus surgery" 58 : 707-718, 1998

      9 Browner WS, "Estimating sample size and power" Williams & Wilkins 139-150, 1988

      10 May M, "Erasorama surgery" 10 : 19-21, 2002

      1 Practice guidelines for acute pain management in the perioperative setting, "an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management" 100 : 1573-1581, 2004

      2 Church CA, "Rofecoxib versus hydrocodone/acetaminophen for postoperative analgesia in functional endoscopic sinus surgery" 116 : 602-606, 2006

      3 Rømsing J, "Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia" 88 : 215-226, 2002

      4 Zhou TJ, "Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement" 92 : 1569-1575, 2001

      5 Dalpiaz AS, "Parecoxib: a shift in pain management?" 4 : 165-177, 2004

      6 Papadima A, "Parecoxib vs. Lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial" 24 : 154-158, 2007

      7 Cheer SM, "Parecoxib (parecoxib sodium)" 61 : 1133-1143, 2001

      8 Slack R, "Functional endoscopic sinus surgery" 58 : 707-718, 1998

      9 Browner WS, "Estimating sample size and power" Williams & Wilkins 139-150, 1988

      10 May M, "Erasorama surgery" 10 : 19-21, 2002

      11 Peduto VA, "Efficacy of propacetamol in the treatment of postoperative pain. Morphine-sparing effect in orthopaedic surgery. Italian Collaborative Group on Propacetamol" 42 : 293-298, 1998

      12 Dolin SJ, "Effectiveness of acute postoperative pain management: I. Evidence from published data" 89 : 409-423, 2002

      13 Ng A, "Early analgesic effects of parcoxib versus ketorolac following laparoscopic sterilization: a randomized controlled trial" 92 : 846-849, 2004

      14 Dannhardt G, "Cyclooxygenase inhibitors- current status and future prospects" 36 : 109-126, 2001

      15 Tilleul P, "Cost analysis applied to postoperative analgesia regimens: a comparison between parecoxib and propacetamol" 29 : 374-379, 2007

      16 Chandrasekharan NV, "COX-3 a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression" 99 : 13926-13931, 2002

      17 Friedman M, "Bupivacaine for postoperative analgesia following endoscopic sinus surgery" 106 : 1382-1385, 1996

      18 Van Aken H, "Assessing analgesia in single and repeated administrations of propacetamol for postoperative pain: comparison with morphine after dental surgery" 98 : 159-165, 2004

      19 Turan A, "Analgesic effects of rofecoxib in ear-nose- throat surgery" 95 : 1308-1311, 2002

      20 Beaussier M, "A randomized, double-blind comparison between parecoxib sodium and propacetamol for parenteral postoperative analgesia after inguinal hernia repair in adult patients" 100 : 1309-1315, 2005

      21 Buchanan MA, "A prospective double-blind randomized controlled trial of the effect of topical bupivacaine on post-operative pain in bilateral nasal surgery with bilateral nasal packs inserted" 119 : 284-288, 2005

      22 Varrassi G, "A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: analgesic efficacy and tolerability after gynecologic surgery" 88 : 611-616, 1999

      23 Bikhazi GB, "A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy" 191 : 1183-1191, 2004

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼